French Health Ministry stops reimbursing 28 drugs, including dronedarone (Multaq)

French Health Ministry stops reimbursing 28 drugs, including dronedarone (Multaq)

Based on a decree dated October 5, 2011, the French Health and Welfare Minister has decided to to stop reimbursing 28 drugs, effective December 1, 2011 including dronedarone (Multaq, Sanofi Aventis), because it compared badly with existing alternatives. More detailed information (in French) at: http://www.has-sante.fr/portail/jcms/c_412202/bon-usage-du-medicament

According to an article published in Prescrire International in August 2010 (The dronedarone odyssey), this drug should not have been approved in the first place. You can read the article (in English) here: http://www.isdbweb.org/documents/forum/the_dronedarone_odyssey.pdf

No Comments

Post A Comment